MassBio head Coughlin set to step down after overseeing massive biopharma expansion in the state during 13-year tenure
The past decade has been good to biopharma, nowhere more so than the bustling and ever-expanding life sciences hub in and around Boston. At the tip of the spear of that expansion is nonprofit trade association MassBio and its long-tenured CEO Robert Coughlin.
Now, Coughlin is stepping aside as the hub continues to bloom.
In an open letter announcing his departure early next year, Coughlin touted the work MassBio has done in his 13 years at the nonprofit amid an industrywide boom that has brought 18 of the top 20 biopharma players to the greater Boston area, he said.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.